Kalpataru Multiplier Ltd.

Our Bank & DP Click for Online Payment MF portfolio login smart way to invest in gold
Sovereign gold bond(SGB) Exchange trades funds(ETF)
CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

Company Profile
more from company profile
HomeMarkets Company Profile Smart Quotes

Smart Quotes

DR. REDDY'S LABORATORIES LTD.

NSE : DRREDDYBSE : 500124ISIN CODE : INE089A01031Industry : Pharmaceuticals & DrugsHouse : Dr. Reddy's
BSE1235.1518 (+1.48 %)
PREV CLOSE () 1217.15
OPEN PRICE () 1218.15
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 728933
TODAY'S LOW / HIGH ()1218.15 1250.35
52 WK LOW / HIGH ()1025.9 1377.95
NSE1235.6018.1 (+1.49 %)
PREV CLOSE() 1217.50
OPEN PRICE () 1230.00
BID PRICE (QTY) 1235.60 (90)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 3888860
TODAY'S LOW / HIGH() 1225.00 1250.80
52 WK LOW / HIGH ()1020 1379.7
BSE NSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1984

Management Info :

K Satish Reddy - Chairman GV Prasad - Managing Director

Registered Office :

Address : 8-2-337,Road No. 3,Banjara Hills,
Hyderabad,
Telangana-500034

Phone : 040 - 4900 2900

Website : www.drreddys.com

Registrar's Details : Bigshare Services Pvt Ltd
306, Right Wing, Amrutha Ville, Opp. Yasodha Hospital,Raj Bhavan Road,Somajiguda,Hyderabad
Listing : BSE, NSE, New York
NEWS
23Jan Dr. Reddy's Laboratories soars on the
Dr. Reddy's Laboratories is currently trading at Rs. 1240.05, up by 22.9..
22Jan Dr. Reddy's Laboratories reports 14% f
Dr. Reddy's Laboratories has reported results for third quarter ended De..
16Jan Dr. Reddy's Laboratories launches Olop
Dr. Reddy's Laboratories has launched over-the-counter (OTC) Olopatadine..
16Jan Dr. Reddy's Laboratories inches up on
Dr. Reddy's Laboratories is currently trading at Rs. 1187.85, up by 1.40..
06Jan Dr Reddys Laboratories informs about c
Dr Reddys Laboratories has informed that it enclosed Confirmation Certif..
Financials
in Millions
QTR Dec 25 ANNUAL 25
Net Profit90653494
Gross Profit 1042 72359
Operating Profit 459983852
Net Sales 42827231154
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Abbott India (BSE)
 27829.85 (0.48%)
M.Cap ( in Cr)
59136.49
Innova Captab (BSE)
 678.40 (3.27%)
M.Cap ( in Cr)
3882.14
Alivus Life Sciences (BSE)
 882.10 (2.36%)
M.Cap ( in Cr)
10826.57
Sudeep Pharma (BSE)
 560.15 (3.43%)
M.Cap ( in Cr)
6326.82
Sanofi India (BSE)
 4070.45 (0.37%)
M.Cap ( in Cr)
9374.50
Shareholding Pattern
PROMOTERS 26.64%
FI/BANKS/INSURANCE 14.06%
MUTUAL FUNDS/UTI 13.87%
NON-INSTITUTION 9.72%
GOVERNMENT 0%
FII 0%
Mf Holding
ATTENTION INVESTORS

Kalpataru Multiplier Ltd.

Kalpataru is a wishful Divine Tree and in present context a widely Trusted, Time tested and Transparent Share Broker, Mutual Fund Distributor and D.P. of this region.

Mobile Trading App
Mobile Trading IOS App
Call Us 0755-4350141/142/143, 9425008895
Mutual Funds 0755-4276725, 4276726
Email Uskmlho@kalpatarumulti.com

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.
SENSEX81537.70-769.67 (-0.94%)
NIFTY25048.65-241.25 (-0.95%)
Dow Jones 49098.71-285.30 (-0.58%)
Nasdaq 23501.2465.22 (0.28%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI